1. Home
  2. NKTX vs CCLD Comparison

NKTX vs CCLD Comparison

Compare NKTX & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • CCLD
  • Stock Information
  • Founded
  • NKTX 2015
  • CCLD 1999
  • Country
  • NKTX United States
  • CCLD United States
  • Employees
  • NKTX N/A
  • CCLD N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • CCLD Computer Software: Prepackaged Software
  • Sector
  • NKTX Health Care
  • CCLD Technology
  • Exchange
  • NKTX Nasdaq
  • CCLD Nasdaq
  • Market Cap
  • NKTX 123.5M
  • CCLD 107.9M
  • IPO Year
  • NKTX 2020
  • CCLD 2014
  • Fundamental
  • Price
  • NKTX $2.37
  • CCLD $2.83
  • Analyst Decision
  • NKTX Strong Buy
  • CCLD Buy
  • Analyst Count
  • NKTX 5
  • CCLD 2
  • Target Price
  • NKTX $13.50
  • CCLD $3.00
  • AVG Volume (30 Days)
  • NKTX 556.1K
  • CCLD 340.3K
  • Earning Date
  • NKTX 08-12-2025
  • CCLD 08-05-2025
  • Dividend Yield
  • NKTX N/A
  • CCLD N/A
  • EPS Growth
  • NKTX N/A
  • CCLD N/A
  • EPS
  • NKTX N/A
  • CCLD 0.00
  • Revenue
  • NKTX N/A
  • CCLD $111,794,000.00
  • Revenue This Year
  • NKTX N/A
  • CCLD $2.20
  • Revenue Next Year
  • NKTX N/A
  • CCLD $7.53
  • P/E Ratio
  • NKTX N/A
  • CCLD $7,045.37
  • Revenue Growth
  • NKTX N/A
  • CCLD 0.04
  • 52 Week Low
  • NKTX $1.31
  • CCLD $1.14
  • 52 Week High
  • NKTX $6.63
  • CCLD $4.84
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 64.66
  • CCLD 66.28
  • Support Level
  • NKTX $2.23
  • CCLD $2.54
  • Resistance Level
  • NKTX $2.50
  • CCLD $2.75
  • Average True Range (ATR)
  • NKTX 0.13
  • CCLD 0.17
  • MACD
  • NKTX 0.02
  • CCLD 0.02
  • Stochastic Oscillator
  • NKTX 76.85
  • CCLD 98.11

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

Share on Social Networks: